References
- Levy-Clarke GA, Greenman D, Sieving PC, et al. Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature. Surv Ophthalmol. 2008;53(3):285–295. doi:10.1016/j.survophthal.2008.02.004.
- Chaput F, Amer R, Baglivo E, et al. Intraocular T-cell lymphoma: clinical presentation, diagnosis, treatment, and outcome. Ocul Immunol Inflamm. 2017;25(5):639–648. doi:10.3109/09273948.2016.1139733.
- Jusufbegovic D, Char DH. Clinical variability of ocular involvement in mycosis fungoides. JAMA Ophthalmol. 2015;133(3):341–343. doi:10.1001/jamaophthalmol.2014.5223.
- Porntharukcharoen S, Rutnin S, Rajatanavin N. Large-cell transformed mycosis fungoides coexisting with mycosis fungoides bullosa: a case report and review of the literature. Case Rep Dermatol. 2017;9(3):243–248. doi:10.1159/000484472.
- Deák GG, Goldstein DA, Zhou M, Fawzi AA, Jampol LM. Vertical hyperreflective lesions on optical coherence tomography in vitreoretinal lymphoma. JAMA Ophthalmol. 2019;137(2):194–198. doi:10.1001/jamaophthalmol.2018.5835.
- Frenkel S, Hendler K, Siegal T, Shalom E, Pe’er J. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthalmol. 2008;92(3):383–388. doi:10.1136/bjo.2007.127928.
- Reddy R, Kim SJ. Intraocular T-cell lymphoma due to mycosis fungoides and response to intravitreal methotrexate. Ocul Immunol Inflamm. 2011;19(4):234–236. doi:10.3109/09273948.2011.563896.